Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Glutamate Receptor Ionotropic NMDA 2B market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Glutamate Receptor Ionotropic NMDA 2Bmarket, defines the market attractiveness level of Glutamate Receptor Ionotropic NMDA 2B market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Glutamate Receptor Ionotropic NMDA 2B industry, describes the types of Glutamate Receptor Ionotropic NMDA 2B market, the applications of major players and the market size, and deeply analyzes the current situation of the global Glutamate Receptor Ionotropic NMDA 2B market and the development prospects and opportunities of Glutamate Receptor Ionotropic NMDA 2B industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Glutamate Receptor Ionotropic NMDA 2B market in Chapter 13.
By Player:
Luc Therapeutics, Inc
BioCrea GmbH
Johnson & Johnson
Cerecor Inc
Novartis AG
UCB SA
Bristol-Myers Squibb Company
NeurOp, Inc
By Type:
JNJ-0808
Neu-2000
NP-10679
NP-11948
Radiprodil
Others
By End-User:
Acute Ischemic Stroke
Autism
Brasin Ischemia
Burns
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Glutamate Receptor Ionotropic NMDA 2B Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Glutamate Receptor Ionotropic NMDA 2B Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Glutamate Receptor Ionotropic NMDA 2B Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Glutamate Receptor Ionotropic NMDA 2B Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Glutamate Receptor Ionotropic NMDA 2B Market Analysis and Outlook to 2022
-
7.1 Global Glutamate Receptor Ionotropic NMDA 2B Consumption (2017-2022)
-
7.2 United States Glutamate Receptor Ionotropic NMDA 2B Consumption (2017-2022)
-
7.3 Europe Glutamate Receptor Ionotropic NMDA 2B Consumption (2017-2022)
-
7.4 China Glutamate Receptor Ionotropic NMDA 2B Consumption (2017-2022)
-
7.5 Japan Glutamate Receptor Ionotropic NMDA 2B Consumption (2017-2022)
-
7.6 India Glutamate Receptor Ionotropic NMDA 2B Consumption (2017-2022)
-
7.7 South Korea Glutamate Receptor Ionotropic NMDA 2B Consumption (2017-2022)
8 Region and Country-wise Glutamate Receptor Ionotropic NMDA 2B Market Analysis and Outlook to 2028
-
8.1 Global Glutamate Receptor Ionotropic NMDA 2B Consumption Forecast (2022-2028)
-
8.2 United States Glutamate Receptor Ionotropic NMDA 2B Consumption Forecast (2022-2028)
-
8.3 Europe Glutamate Receptor Ionotropic NMDA 2B Consumption Forecast (2022-2028)
-
8.4 China Glutamate Receptor Ionotropic NMDA 2B Consumption Forecast (2022-2028)
-
8.5 Japan Glutamate Receptor Ionotropic NMDA 2B Consumption Forecast (2022-2028)
-
8.6 India Glutamate Receptor Ionotropic NMDA 2B Consumption Forecast (2022-2028)
-
8.7 South Korea Glutamate Receptor Ionotropic NMDA 2B Consumption Forecast (2022-2028)
9 Global Glutamate Receptor Ionotropic NMDA 2B Market Outlook by Types and Applications to 2022
-
9.1 Global Glutamate Receptor Ionotropic NMDA 2B Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global JNJ-0808 Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Neu-2000 Consumption and Growth Rate (2017-2022)
-
9.1.3 Global NP-10679 Consumption and Growth Rate (2017-2022)
-
9.1.4 Global NP-11948 Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Radiprodil Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Glutamate Receptor Ionotropic NMDA 2B Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Acute Ischemic Stroke Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Autism Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Brasin Ischemia Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Burns Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Others Consumption and Growth Rate (2017-2022)
10 Global Glutamate Receptor Ionotropic NMDA 2B Market Outlook by Types and Applications to 2028
-
10.1 Global Glutamate Receptor Ionotropic NMDA 2B Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global JNJ-0808 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Neu-2000 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global NP-10679 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global NP-11948 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Radiprodil Consumption Forecast and Growth Rate (2022-2028)
-
10.1.6 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Glutamate Receptor Ionotropic NMDA 2B Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Acute Ischemic Stroke Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Autism Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Brasin Ischemia Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Burns Consumption Forecast and Growth Rate (2022-2028)
-
10.2.5 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Glutamate Receptor Ionotropic NMDA 2B Import and Export Analysis (Top 5 Countries)
-
11.1 Global Glutamate Receptor Ionotropic NMDA 2B Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Glutamate Receptor Ionotropic NMDA 2B Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Glutamate Receptor Ionotropic NMDA 2B Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Glutamate Receptor Ionotropic NMDA 2B Market Competitive Analysis
-
14.1 Luc Therapeutics, Inc
-
14.1.1 Luc Therapeutics, Inc Company Details
-
14.1.2 Luc Therapeutics, Inc Glutamate Receptor Ionotropic NMDA 2B Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Luc Therapeutics, Inc Glutamate Receptor Ionotropic NMDA 2B Product and Service
-
14.2 BioCrea GmbH
-
14.2.1 BioCrea GmbH Company Details
-
14.2.2 BioCrea GmbH Glutamate Receptor Ionotropic NMDA 2B Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 BioCrea GmbH Glutamate Receptor Ionotropic NMDA 2B Product and Service
-
14.3 Johnson & Johnson
-
14.3.1 Johnson & Johnson Company Details
-
14.3.2 Johnson & Johnson Glutamate Receptor Ionotropic NMDA 2B Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Johnson & Johnson Glutamate Receptor Ionotropic NMDA 2B Product and Service
-
14.4 Cerecor Inc
-
14.4.1 Cerecor Inc Company Details
-
14.4.2 Cerecor Inc Glutamate Receptor Ionotropic NMDA 2B Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Cerecor Inc Glutamate Receptor Ionotropic NMDA 2B Product and Service
-
14.5 Novartis AG
-
14.5.1 Novartis AG Company Details
-
14.5.2 Novartis AG Glutamate Receptor Ionotropic NMDA 2B Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Novartis AG Glutamate Receptor Ionotropic NMDA 2B Product and Service
-
14.6 UCB SA
-
14.6.1 UCB SA Company Details
-
14.6.2 UCB SA Glutamate Receptor Ionotropic NMDA 2B Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 UCB SA Glutamate Receptor Ionotropic NMDA 2B Product and Service
-
14.7 Bristol-Myers Squibb Company
-
14.7.1 Bristol-Myers Squibb Company Company Details
-
14.7.2 Bristol-Myers Squibb Company Glutamate Receptor Ionotropic NMDA 2B Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Bristol-Myers Squibb Company Glutamate Receptor Ionotropic NMDA 2B Product and Service
-
14.8 NeurOp, Inc
-
14.8.1 NeurOp, Inc Company Details
-
14.8.2 NeurOp, Inc Glutamate Receptor Ionotropic NMDA 2B Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 NeurOp, Inc Glutamate Receptor Ionotropic NMDA 2B Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Glutamate Receptor Ionotropic NMDA 2B
-
Figure Glutamate Receptor Ionotropic NMDA 2B Picture
-
Table Global Glutamate Receptor Ionotropic NMDA 2B Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Glutamate Receptor Ionotropic NMDA 2B Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Glutamate Receptor Ionotropic NMDA 2B Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Glutamate Receptor Ionotropic NMDA 2B Consumption by Country (2017-2022)
-
Figure United States Glutamate Receptor Ionotropic NMDA 2B Consumption and Growth Rate (2017-2022)
-
Table Europe Glutamate Receptor Ionotropic NMDA 2B Consumption and Growth Rate (2017-2022)
-
Figure China Glutamate Receptor Ionotropic NMDA 2B Consumption and Growth Rate (2017-2022)
-
Figure Japan Glutamate Receptor Ionotropic NMDA 2B Consumption and Growth Rate (2017-2022)
-
Figure India Glutamate Receptor Ionotropic NMDA 2B Consumption and Growth Rate (2017-2022)
-
Figure South Korea Glutamate Receptor Ionotropic NMDA 2B Consumption and Growth Rate (2017-2022)
-
Figure Global Glutamate Receptor Ionotropic NMDA 2B Consumption Forecast by Country (2022-2028)
-
Figure United States Glutamate Receptor Ionotropic NMDA 2B Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Glutamate Receptor Ionotropic NMDA 2B Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Glutamate Receptor Ionotropic NMDA 2B Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Glutamate Receptor Ionotropic NMDA 2B Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Glutamate Receptor Ionotropic NMDA 2B Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Glutamate Receptor Ionotropic NMDA 2B Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global JNJ-0808 Consumption and Growth Rate (2017-2022)
-
Figure Global Neu-2000 Consumption and Growth Rate (2017-2022)
-
Figure Global NP-10679 Consumption and Growth Rate (2017-2022)
-
Figure Global NP-11948 Consumption and Growth Rate (2017-2022)
-
Figure Global Radiprodil Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Acute Ischemic Stroke Consumption and Growth Rate (2017-2022)
-
Figure Global Autism Consumption and Growth Rate (2017-2022)
-
Figure Global Brasin Ischemia Consumption and Growth Rate (2017-2022)
-
Figure Global Burns Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global JNJ-0808 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Neu-2000 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global NP-10679 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global NP-11948 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Radiprodil Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Acute Ischemic Stroke Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Autism Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Brasin Ischemia Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Burns Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Glutamate Receptor Ionotropic NMDA 2B Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Glutamate Receptor Ionotropic NMDA 2B Export by Region (Top 5 Countries) (2017-2028)
-
Table Luc Therapeutics, Inc (Foundation Year, Company Profile and etc.)
-
Table Luc Therapeutics, Inc Glutamate Receptor Ionotropic NMDA 2B Sales, Price, Value and Gross Profit (2017-2022)
-
Table Luc Therapeutics, Inc Glutamate Receptor Ionotropic NMDA 2B Product and Service
-
Table BioCrea GmbH (Foundation Year, Company Profile and etc.)
-
Table BioCrea GmbH Glutamate Receptor Ionotropic NMDA 2B Sales, Price, Value and Gross Profit (2017-2022)
-
Table BioCrea GmbH Glutamate Receptor Ionotropic NMDA 2B Product and Service
-
Table Johnson & Johnson (Foundation Year, Company Profile and etc.)
-
Table Johnson & Johnson Glutamate Receptor Ionotropic NMDA 2B Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Glutamate Receptor Ionotropic NMDA 2B Product and Service
-
Table Cerecor Inc (Foundation Year, Company Profile and etc.)
-
Table Cerecor Inc Glutamate Receptor Ionotropic NMDA 2B Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cerecor Inc Glutamate Receptor Ionotropic NMDA 2B Product and Service
-
Table Novartis AG (Foundation Year, Company Profile and etc.)
-
Table Novartis AG Glutamate Receptor Ionotropic NMDA 2B Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis AG Glutamate Receptor Ionotropic NMDA 2B Product and Service
-
Table UCB SA (Foundation Year, Company Profile and etc.)
-
Table UCB SA Glutamate Receptor Ionotropic NMDA 2B Sales, Price, Value and Gross Profit (2017-2022)
-
Table UCB SA Glutamate Receptor Ionotropic NMDA 2B Product and Service
-
Table Bristol-Myers Squibb Company (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Company Glutamate Receptor Ionotropic NMDA 2B Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Company Glutamate Receptor Ionotropic NMDA 2B Product and Service
-
Table NeurOp, Inc (Foundation Year, Company Profile and etc.)
-
Table NeurOp, Inc Glutamate Receptor Ionotropic NMDA 2B Sales, Price, Value and Gross Profit (2017-2022)
-
Table NeurOp, Inc Glutamate Receptor Ionotropic NMDA 2B Product and Service
-
